Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Dalton Transactions (Cambridge, England : 2003)|July 23, 2025
Evaluating a triaza-18-crown-6 picolinate chelator for [212/203Pb]Pb2+ and [212/213Bi]Bi3+ theranosticsDesiree Fiaccabrino, Tinotenda Masvikeni, Brooke L McNeil, et al.
Nature|May 9, 2003
Defective membrane repair in dysferlin-deficient muscular dystrophyDimple Bansal, Katsuya Miyake, Steven S Vogel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 24, 2010
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaRobyn J Levy, William R Lumry, Donald L McNeil, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 3, 2018
The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouthNamita Sinha, Matthew H Rigby, Michael L McNeil, et al.
Dalton Transactions (Cambridge, England : 2003)|August 5, 2021
Getting a lead on Pb2+-amide chelators for 203/212Pb radiopharmaceuticalsAidan Ingham, Thomas I Kostelnik, Brooke L McNeil, et al.
EJNMMI Radiopharmacy and Chemistry|June 6, 2022
Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imagingAnthony W McDonagh, Brooke L McNeil, Julie Rousseau, et al.
Nuclear Medicine and Biology|June 1, 2025
Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3Ina Hierlmeier, Parmissa Randhawa, Brooke L McNeil, et al.
Pageof 17